Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling

References

• Andreasen PA, Kjoller L, Christensen L, Duffy MJ. (1997). The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72 (1):1–22.
   PubMed Web of Science ®Google Scholar
• Archer SL. (2010). The mitochondrion as a Swiss army knife: implications for cardiovascular disease. J Mol Med (Berl) 88(10):963–5.
   PubMed Web of Science ®Google Scholar
• Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS. (2003). Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med. 197(5):615–24.
   PubMed Web of Science ®Google Scholar
• Becker A, Smulders YM, van GC, Stehouwer CD. (2003). Epidemiology of homocysteine as a risk factor in diabetes. Metab Syndr Relat Disord 1(2):105–20.
   PubMed Web of Science ®Google Scholar
• Bendeck MP, Irvin C, Reidy MA. (1996). Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78(1):38–43.
   PubMed Web of Science ®Google Scholar
• Berman RS, Martin W. (1993). Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Br J Pharmacol 108(4):920–26.
   PubMed Web of Science ®Google Scholar
• Beyer EC, Kistler J, Paul DL, Goodenough DA. (1989). Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol 108(2):595–605.
   PubMed Web of Science ®Google Scholar
• Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354(15):1578–88.
   PubMed Web of Science ®Google Scholar
• Brady AJ, Warren B., Poole-Wilson PA, Williams TJ, Harding SE. (1993). Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265(1 Pt 2) H176–82.
   PubMed Web of Science ®Google Scholar
• Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N. (2004). Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 37(6):755–67.
   PubMed Web of Science ®Google Scholar
• Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen H, Nenseter MS. (1999). Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest 29(2):100–8.
   PubMed Web of Science ®Google Scholar
• Cai B, Shan L, Gong D, Pan Z, Ai J, Xu C, Lu Y, Yang B. (2009). Homocysteine modulates sodium channel currents in human atrial myocytes. Toxicology 256(3):201–6.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Bouche A, De CC, Janssen S, Pollefeyt S, Wyns S, Mulligan RC, Collen D. (1995). Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice. Ann NY Acad Sci 748:367–81.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD. (1997). Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96(9):3180–91.
   PubMed Web of Science ®Google Scholar
• Cho A, Reidy MA. (2002). Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91(9):845–51.
   PubMed Web of Science ®Google Scholar
• Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. (1990). Smooth muscle cells express urokinase during mitogenesis and tissue–type plasminogen activator during migration in injured rat carotid artery. Circ Res 67(1):61–7.
   PubMed Web of Science ®Google Scholar
• Colucci WS, Alexander RW, Williams GH, Rude RE, Holman BL, Konstam MA, Wynne J, Mudge GH Jr, Braunwald E. (1981). Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med 305(4):185–90.
   PubMed Web of Science ®Google Scholar
• Coppen SR, Dupont E, Rothery S, Severs NJ. (1998). Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82(2):232–43.
   PubMed Web of Science ®Google Scholar
• Cullen JP, Nicholl SM, Sayeed S, Sitzmann JV, Okada SS, Cahill PA, Redmond EM. (2004). Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration. Thromb Res 114(1):57–65.
   PubMed Web of Science ®Google Scholar
• D’Amico M, Di FC, Rossi F, Rossi F. (1999). Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. Eur J Pharmacol 366(2–3):167–74.
   PubMed Web of Science ®Google Scholar
• Dalton TP, Shertzer HG, Puga A. (1999). Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39:67–101.
   PubMed Web of Science ®Google Scholar
• de Smet BJ, de KD, Hanemaaijer R, Verheijen JH, Robertus L, van Der Helm YJ, Borst C, Post MJ. (2000). Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig. Circulation 101(25):2962–7.
   PubMed Web of Science ®Google Scholar
• Dhamija RK, Gaba P, Arora S, Kaintura A, Kumar M, Bhattacharjee J. (2009). Homocysteine and lipoprotein (a) correlation in ischemic stroke patients. J Neurol Sci 281(1–2):64–8.
   PubMed Web of Science ®Google Scholar
• Dollery CM, McEwan JR, Henney AM. (1995). Matrix metalloproteinases and cardiovascular disease. Circ Res 77(5):863–8.
   PubMed Web of Science ®Google Scholar
• Du C, Fang M, Li Y, Li L, Wang X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102(1):33–42.
   PubMed Web of Science ®Google Scholar
• Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, Zervos AS. (2000). Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 275(4):2581–8.
   PubMed Web of Science ®Google Scholar
• Fedak PW, Altamentova SM, Weisel RD, Nili N, Ohno N, Verma S, Lee TY, Kiani C, Mickle DA, Strauss BH, Li RK. (2003). Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am J Physiol Heart Circ Physiol 284(2):H626–34.
   PubMed Web of Science ®Google Scholar
• Ferlazzo N, Condello S, Curro M, Parisi G, Ientile R, Caccamo D. (2008). NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells. BMC Neurosci 9:62.
   PubMed Web of Science ®Google Scholar
• Folbergrova J. (1994). NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats. Exp Neurol 130(2):344–50.
   PubMed Web of Science ®Google Scholar
• Fu X, Kassim SY, Parks WC, Heinecke JW. (2001). Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276(44):41279–87.
   PubMed Web of Science ®Google Scholar
• Gao X, Xu X, Pang J, Zhang C, Ding JM, Peng X, Liu Y, Cao JM. (2007). NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol Res 56(5):559–69.
   PubMed Web of Science ®Google Scholar
• Gillespie W, Tyagi N, Tyagi SC. (2011). Role of PPARgamma, a nuclear hormone receptor in neuroprotection. Indian J Biochem Biophys 48(2):73–81.
   PubMed Web of Science ®Google Scholar
• Givvimani S, Qipshidze N, Tyagi N, Mishra PK, Sen U, Tyagi SC. (2011). Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease. Int J Physiol Pathophysiol Pharmacol 3(2):107–19.
   PubMedGoogle Scholar
• Gottlieb E, Armour SM, Harris MH, Thompson CB. (2003). Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10(6):709–17.
   PubMed Web of Science ®Google Scholar
• Gray CW et al. (2000). Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267(18):5699–710.
   PubMedGoogle Scholar
• Gros D, Dupays L, Alcolea S, Meysen S, Miquerol L, Theveniau-Ruissy, M. (2004). Genetically modified mice: tools to decode the functions of connexins in the heart − new models for cardiovascular research. Cardiovasc Res 62(2):299–308.
   PubMed Web of Science ®Google Scholar
• Gros DB, Jongsma HJ. (1996). Connexins in mammalian heart function. Bioessays 18(9):719–730.
   PubMed Web of Science ®Google Scholar
• Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO. (2011). Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278(1):28–45.
   PubMed Web of Science ®Google Scholar
• Hansson Petersen CA et al. (2008). The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 105(35):13145–50.
   PubMed Web of Science ®Google Scholar
• Hasenstab D, Lea H, Clowes AW. (2000). Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler Thromb Vasc Biol 20(3):853–9.
   PubMed Web of Science ®Google Scholar
• Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. (2000). Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106(11):1341–50.
   PubMed Web of Science ®Google Scholar
• Heistad DD, Lopez JA, Baumbach GL. (1991). Hemodynamic determinants of vascular changes in hypertension and atherosclerosis. Hypertension 17(4 Suppl) III7–11.
   PubMedGoogle Scholar
• Heymans S, Lupu F, Terclavers S, Vanwetswinkel B, Herbert JM, Baker A, Collen D, Carmeliet P, Moons L. (2005). Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am J Pathol 166(1):15–25.
   PubMed Web of Science ®Google Scholar
• Hofmann MA et al. (1997). Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 20(12):1880–86.
   PubMed Web of Science ®Google Scholar
• Hofmann MA et al. (2001). Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107(6):675–83.
   PubMed Web of Science ®Google Scholar
• Huang CF, Su MJ. (1999). Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci 6(6):387–98.
   PubMed Web of Science ®Google Scholar
• Huijberts MS, Becker A, Stehouwer CD. (2005). Homocysteine and vascular disease in diabetes: a double hit? Clin Chem Lab Med 43(10):993–1000.
   PubMed Web of Science ®Google Scholar
• Hunt MJ, Aru GM, Hayden MR, Moore CK, Hoit BD, Tyagi SC. (2002). Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 283(2):L239–45.
   PubMed Web of Science ®Google Scholar
• Hunt MJ, Tyagi SC. (2002). Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation. Am J Physiol Cell Physiol 283(4):C1073–9.
   PubMed Web of Science ®Google Scholar
• Iimoto DS, Covell JW, Harper E. (1988). Increase in cross-linking of type I and type III collagens associated with volume-overload hypertrophy. Circ Res 63(2):399–408.
   PubMed Web of Science ®Google Scholar
• Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S. (2001). The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50(1):3–11.
   PubMed Web of Science ®Google Scholar
• Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawai S, Nakajima T, Hokari S, Komoda T, Katayama S. (2000). Lipophilic HMG-CoA reductase inhibitor has an anti–inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. Life Sci 67(8):863–76.
   PubMed Web of Science ®Google Scholar
• Inoue I, Noji S, Awata T, Takahashi K, Nakajima T, Sonoda M, Komoda T, Katayama S. (1998). Bezafibrate has an antioxidant effect: peroxisome proliferator–activated receptor alpha is associated with Cu2+, Zn2+–superoxide dismutase in the liver. Life Sci., 63, (2) 135–144 available from: PM:9674948
   PubMed Web of Science ®Google Scholar
• Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. (1989). Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64(6):1041–50.
   PubMed Web of Science ®Google Scholar
• Jiang F, Zhang Y, Dusting GJ. (2011). NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 63(1):218–42.
   PubMed Web of Science ®Google Scholar
• Kagaya S, Kitanaka C, Noguchi K, Mochizuki T, Sugiyama A, Asai A, Yasuhara N, Eguchi Y, Tsujimoto Y, Kuchino Y. (1997). A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis. Mol Cell Biol 17(11):6736–45.
   PubMed Web of Science ®Google Scholar
• Kenagy RD, Vergel S, Mattsson E, Bendeck M, Reidy MA, Clowes AW. (1996). The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arterioscler Thromb Vasc Biol 16(11):1373–82.
   PubMed Web of Science ®Google Scholar
• Krainc D, Bai G, Okamoto S, Carles M, Kusiak JW, Brent RN, Lipton SA. (1998). Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. J Biol Chem 273(40):26218–24.
   PubMed Web of Science ®Google Scholar
• Kreuzberg MM, Schrickel JW, Ghanem A, Kim JS, Degen J, Janssen-Bienhold U, Lewalter T, Tiemann K, Willecke K. (2006). Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proc Natl Acad Sci USA 103(15):5959–64.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Reed JC. (2000). Mitochondrial control of cell death. Nat Med 6(5):513–19.
   PubMed Web of Science ®Google Scholar
• Kruger O, Plum A, Kim JS, Winterhager E, Maxeiner S, Hallas G, Kirchhoff S, Traub O, Lamers WH, Willecke K. (2000). Defective vascular development in connexin 45-deficient mice. Development 127(19):4179–93.
   PubMed Web of Science ®Google Scholar
• Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. (1997). Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81(4) 627–35.
   PubMed Web of Science ®Google Scholar
• Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R. (2004). Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 18(6):690–92.
   PubMedGoogle Scholar
• Lee TI, Kao YH, Chen YC, Pan NH, Lin YK, Chen YJ. (2011). Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes. Clin Sci (Lond) 121 (7):305–12.
   PubMed Web of Science ®Google Scholar
• Li LY, Luo X, Wang X. (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412(6842):95–99.
   PubMed Web of Science ®Google Scholar
• Li X, Simard JM. (1999). Multiple connexins form gap junction channels in rat basilar artery smooth muscle cells. Circ Res 84(11):1277–84.
   PubMed Web of Science ®Google Scholar
• Li YF, Cornish KG, Patel KP. (2003). Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 93(10):990–97.
   PubMed Web of Science ®Google Scholar
• Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM. (2000a). Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97(23):12746–51.
   PubMed Web of Science ®Google Scholar
• Li YY, Kadokami T, Wang P, McTiernan CF, Feldman AM. (2002). MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. Am J Physiol Heart Circ Physiol 282(3):H983–9.
   PubMed Web of Science ®Google Scholar
• Li YY, McTiernan CF, Feldman AM. (2000b). Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46(2):214–24.
   PubMed Web of Science ®Google Scholar
• Lijnen HR. (2001). Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86(1):324–333.
   PubMed Web of Science ®Google Scholar
• Limb GA, Matter K, Murphy G, Cambrey AD, Bishop PN, Morris GE, Khaw PT. (2005). Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am J Pathol 166(5):1555–63.
   PubMed Web of Science ®Google Scholar
• Liu RM, Gaston Pravia KA. (2010). Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med 48(1):1–15.
   PubMed Web of Science ®Google Scholar
• Liu X, Kim CN, Yang J, Jemmerson R, Wang X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147–57.
   PubMed Web of Science ®Google Scholar
• Loscalzo J. (2006). Homocysteine trials––clear outcomes for complex reasons. N Engl J Med 354(15):1629–32.
   PubMed Web of Science ®Google Scholar
• Loskutoff DJ, Quigley JP. (2000). PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 106 (12):1441–3.
   PubMed Web of Science ®Google Scholar
• Malemud CJ. (2006). Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696–701.
   PubMed Web of Science ®Google Scholar
• Mann DL, Taegtmeyer H. (2001). Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: recovering the missing link in left ventricular remodeling. Circulation 104(10):1089–91.
   PubMed Web of Science ®Google Scholar
• Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 238(2):343–6.
   PubMed Web of Science ®Google Scholar
• Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J. (2010). NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 85(3):473–83.
   PubMed Web of Science ®Google Scholar
• Marx N, Sukhova G, Murphy C, Libby P, Plutzky J. (1998). Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 153(1):17–23.
   PubMed Web of Science ®Google Scholar
• Maurer M, Burri S, de MS, Hullin R, Martinelli M, Mohacsi P, Hess OM. (2010). Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. Int J Cardiol 141(1):32–8.
   PubMed Web of Science ®Google Scholar
• McCawley LJ, Matrisian LM. (2001). Matrix metalloproteinases: they’re not just for matrix anymore! Curr Opin Cell Biol 13(5):534–40.
   PubMed Web of Science ®Google Scholar
• McElmurray III JH et al. (1999). Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther 291(2):799–811.
   PubMed Web of Science ®Google Scholar
• McGregor D, Shand B, Lynn K. (2000). A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron 85(3):215–20.
   PubMedGoogle Scholar
• Milani RV, Lavie CJ. (2008). Homocysteine: the Rubik’s cube of cardiovascular risk factors. Mayo Clin Proc 83(11):1200–202.
   PubMed Web of Science ®Google Scholar
• Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. (1996). Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94(1):35–43.
   PubMed Web of Science ®Google Scholar
• Miquerol L, Meysen S, Mangoni M, Bois P, van Rijen HV, Abran P, Jongsma H, Nargeot J, Gros D. (2004). Architectural and functional asymmetry of the His-Purkinje system of the murine heart. Cardiovasc Res 63(1):77–86.
   PubMed Web of Science ®Google Scholar
• Mondy JS, Williams JK, Adams MR, Dean RH, Geary RL. (1997). Structural determinants of lumen narrowing after angioplasty in atherosclerotic nonhuman primates. J Vasc Surg 26(5):875–83
   PubMed Web of Science ®Google Scholar
• Moshal KS, Kumar M, Tyagi N, Mishra PK, Metreveli N, Rodriguez WE, Tyagi SC. (2009). Restoration of contractility in hyperhomocysteinemia by cardiac–specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 296(3):H887–92.
   PubMed Web of Science ®Google Scholar
• Moshal KS, Metreveli N, Frank I, Tyagi SC. (2008a). Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol 6(2):84–92.
   PubMed Web of Science ®Google Scholar
• Moshal KS, Rodriguez WE, Sen U, Tyagi SC. (2008b). Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure. Physiol Res 57(3):379–84.
   PubMed Web of Science ®Google Scholar
• Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC. (2006). Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291(6):H2825–35.
   PubMed Web of Science ®Google Scholar
• Moshal KS et al. (2008c). Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 295(2):H890–97.
   PubMed Web of Science ®Google Scholar
• Moshal KS, Tyagi N, Henderson B, Ovechkin AV, Tyagi SC. (2005). Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 288(6):H2770–77.
   PubMed Web of Science ®Google Scholar
• Mujumdar VS, Aru GM, Tyagi SC. (2001). Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82(3):491–500.
   PubMed Web of Science ®Google Scholar
• Mujumdar VS, Tummalapalli CM, Aru GM, Tyagi SC. (2002). Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. Am J Physiol Cell Physiol 282(5):C1009–15.
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Sen S. (1990). Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 67(6):1474–80.
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley III AJ, Spinale FG, Gold MR. (2006). Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97(4):532–7.
   PubMed Web of Science ®Google Scholar
• Nasir K, Tsai M, Rosen BD, Fernandes V, Bluemke DA, Folsom AR, Lima JA. (2007). Elevated homocysteine is associated with reduced regional left ventricular function: the multi-ethnic study of atherosclerosis. Circulation 115 (2):180–87.
   PubMed Web of Science ®Google Scholar
• Nelson KK, Melendez JA. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37(6):768–84.
   PubMed Web of Science ®Google Scholar
• Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ. (1997). Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96(6):1991–8.
   PubMed Web of Science ®Google Scholar
• Ntaios G et al. 2010. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial. Int J Cardiol 143(1):16–19.
   PubMed Web of Science ®Google Scholar
• Ow YP, Green DR, Hao Z, Mak TW. (2008). Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9(7):532–42.
   PubMed Web of Science ®Google Scholar
• Pavia C, Ferrer I, Valls C, Artuch R, Colome C, Vilaseca MA. (2000). Total homocysteine in patients with type 1 diabetes. Diabetes Care 23(1):84–87.
   PubMed Web of Science ®Google Scholar
• Pei D, Kang T, Qi H. (2000). Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem 275(43);33988–97.
   PubMed Web of Science ®Google Scholar
• Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, Malinski T. (1997). Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 81(3):372–379.
   PubMed Web of Science ®Google Scholar
• Popp O, Heidinger M, Ruiz-Heinrich L, Ries C, Jochum M, Gil-Parrado S. (2003). The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells. Biol Chem 384(6);951–8.
   PubMed Web of Science ®Google Scholar
• Poynter ME, Daynes RA. (1998). Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273(49):32833–41.
   PubMed Web of Science ®Google Scholar
• Qureshi I et al. (2005). Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med 10(3);215–223.
   PubMed Web of Science ®Google Scholar
• Rackauskas M, Kreuzberg MM, Pranevicius M, Willecke K, Verselis VK, Bukauskas FF. (2007). Gating properties of heterotypic gap junction channels formed of connexins 40, 43, and 45. Biophys J 92(6):1952–65.
   PubMed Web of Science ®Google Scholar
• Ranganathan AC et al. 2001. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2–dependent ERK1/2 activation. J Biol Chem 276(17):14264–14270.
   PubMed Web of Science ®Google Scholar
• Rassow J, Maarse AC, Krainer E, Kubrich M, Muller H, Meijer M, Craig EA, & Pfanner, N. 1994. Mitochondrial protein import: biochemical and genetic evidence for interaction of matrix hsp70 and the inner membrane protein MIM44. J Cell Biol 127(6 Pt 1):1547–556.
   PubMed Web of Science ®Google Scholar
• Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. (1995). Cardiac malformation in neonatal mice lacking connexin43. Science 267(5205):1831–4.
   PubMed Web of Science ®Google Scholar
• Robillon JF, Canivet B, Candito M, Sadoul JL, Jullien D, Morand P, Chambon P, Freychet P. (1994). Type 1 diabetes mellitus and homocyst(e)ine. Diabete Metab 20(5):494–6.
   PubMed Web of Science ®Google Scholar
• Rodriguez WE, Tyagi N, Deng AY, Adeagbo A, Joshua IG, Tyagi SC. (2008). Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy. Arch Physiol Biochem 114(5):340–348.
   PubMedGoogle Scholar
• Ross R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801–9.
   PubMed Web of Science ®Google Scholar
• Ruan L, Chen W, Srinivasan SR, Xu J, Sun M, Toprak A, Berenson GS. (2009). Relation of plasma homocysteine to arterial stiffness in black and white young adults (from the Bogalusa Heart Study). Am J Cardiol 103(7):985–8.
   PubMed Web of Science ®Google Scholar
• Rucklidge GJ, Milne G, McGaw BA, Milne E, Robins SP. (1992). Turnover rates of different collagen types measured by isotope ratio mass spectrometry. Biochim Biophys Acta 1156(1):57–61.
   PubMed Web of Science ®Google Scholar
• Saari H, Sorsa T, Lindy O, Suomalainen K, Halinen S, Konttinen YT. (1992). Reactive oxygen species as regulators of human neutrophil and fibroblast interstitial collagenases. Int J Tissue React 14(3):113–20.
   PubMedGoogle Scholar
• Schmalfeldt B et al. (2001). Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7(8):2396–404.
   PubMed Web of Science ®Google Scholar
• Schulz R. 2007. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47:211–242.
   PubMed Web of Science ®Google Scholar
• Schulz R, Heusch G. (2006). Connexin43 and ischemic preconditioning. Adv Cardiol 42:213–27.
   PubMed Web of Science ®Google Scholar
• Schwartz SM. (1997). Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 100(11 Suppl):S87–9.
   PubMed Web of Science ®Google Scholar
• Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J. (2006). Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169(4):1390–1401.
   PubMed Web of Science ®Google Scholar
• Singh K, Communal C, Sawyer DB., Colucci WS. (2000). Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 45(3):713–19.
   PubMed Web of Science ®Google Scholar
• Soinio, M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. (2004). Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 140(2):94–100.
   PubMed Web of Science ®Google Scholar
• Sood HS, Cox MJ, Tyagi SC. (2002). Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid Redox Signal 4(5):799–804.
   PubMed Web of Science ®Google Scholar
• Spiess C, Beil A, Ehrmann M. (1999). A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 97(3):339–47.
   PubMed Web of Science ®Google Scholar
• Susin SA et al. (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397(6718):441–6.
   PubMed Web of Science ®Google Scholar
• Takenouchi Y, Kobayashi T, Taguchi K, Matsumoto T, Kamata K. (2010). Relationship among superoxide-related enzyme, PPARs, and endothelium-dependent relaxation in murine aortas previously organ-cultured in high-glucose conditions. Can J Physiol Pharmacol 88(7):760–69.
   PubMed Web of Science ®Google Scholar
• Takeshita K et al. (2004). Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction. Am J Pathol 164(2):449–56.
   PubMed Web of Science ®Google Scholar
• Tamaddon HS, Vaidya D, Simon AM, Paul DL, Jalife J, Morley GE. (2000). High-resolution optical mapping of the right bundle branch in connexin40 knockout mice reveals slow conduction in the specialized conduction system. Circ Res 87(10):929–36.
   PubMed Web of Science ®Google Scholar
• Tanaka F, Ogura N, Abiko Y. (1997). Stimulation of plasminogen activator/plasmin system in gingival fibroblast cells by oxygen radicals. Arch Oral Biol 42(4):263–270.
   PubMed Web of Science ®Google Scholar
• Tarkun I, Cetinarslan B, Canturk Z, Tarkun P, Agacdiken A, Komsuoglu B. (2004). Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker. J Diabetes Complications 18(3):165–8.
   PubMed Web of Science ®Google Scholar
• Taskinen MR, Sullivan DR, Ehnholm C, Whiting M, Zannino D, Simes RJ, Keech AC, Barter PJ. (2009). Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol 29(6):950–955.
   PubMed Web of Science ®Google Scholar
• Tikhomirov O, Carpenter G. (2005). Bax activation and translocation to mitochondria mediate EGF-induced programmed cell death. J Cell Sci 118(Pt 24):5681–90.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. (2004). Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 22(6):1141–9.
   PubMed Web of Science ®Google Scholar
• Tummalapalli CM, Tyagi SC. (1999). Responses of vascular smooth muscle cell to extracellular matrix degradation. J Cell Biochem 75(3):515–27.
   PubMed Web of Science ®Google Scholar
• Turrens JF. (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552(Pt 2):335–44.
   PubMed Web of Science ®Google Scholar
• Tyagi N., Vacek JC, Givvimani S, Sen U, Tyagi SC. (2010). Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J Recept Signal Transduct Res 30(2):78–87.
   PubMed Web of Science ®Google Scholar
• Tyagi SC. (1999). Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens 21(3):181–98.
   PubMed Web of Science ®Google Scholar
• van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, de Bakker JM. (2004). Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 109(8):1048–55.
   PubMed Web of Science ®Google Scholar
• van Rijen HV, van Veen TA, van Kempen MJ, Wilms-Schopman FJ, Potse M, Krueger O, Willecke K, Opthof T, Jongsma HJ, de Bakker JM. (2001). Impaired conduction in the bundle branches of mouse hearts lacking the gap junction protein connexin40. Circulation 103(11):1591–8.
   PubMed Web of Science ®Google Scholar
• Van LG et al. 2002a. A matrix-assisted laser desorption ionization post-source decay (MALDI-PSD) analysis of proteins released from isolated liver mitochondria treated with recombinant truncated Bid. Cell Death Differ 9(3);301–8.
   PubMed Web of Science ®Google Scholar
• Van LG et al. (2001). Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8(12):1136–42.
   PubMed Web of Science ®Google Scholar
• Van LG, Van GM, Depuydt B, Srinivasula SM, Rodriguez I, Alnemri ES, Gevaert K, Vandekerckhove, J, Declercq W, Vandenabeele P. (2002b). The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 9(1):20–26.
   PubMed Web of Science ®Google Scholar
• Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102(1):43–53.
   PubMed Web of Science ®Google Scholar
• Verheijck EE, van Kempen MJ, Veereschild M, Lurvink J, Jongsma HJ, Bouman LN. (2001). Electrophysiological features of the mouse sinoatrial node in relation to connexin distribution. Cardiovasc Res 52(1):40–50.
   PubMed Web of Science ®Google Scholar
• Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. (2002). Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106(12):1543–9.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG, Campbell SE, Zhou, G, Matsubara L, Guarda E. (1992). Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. Blood Press 1(2):75–85.
   PubMedGoogle Scholar
• Weber KT, Pick R, Jalil JE, Janicki JS, Carroll EP. (1989). Patterns of myocardial fibrosis. J Mol Cell Cardiol 21(Suppl 5):121–131.
   PubMedGoogle Scholar
• Wijekoon EP, Brosnan ME, Brosnan JT. (2007). Homocysteine metabolism in diabetes. Biochem Soc Trans 35(Pt 5):1175–9.
   PubMedGoogle Scholar
• Wilcken DE, Wilcken B. (1976). The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57(4):1079–82.
   PubMed Web of Science ®Google Scholar
• Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. (1993). Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 123(3):741–7.
   PubMed Web of Science ®Google Scholar
• Wright SC, Schellenberger U, Wang H, Kinder DH, Talhouk JW, Larrick JW. (1997). Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med 186(7):1107–17.
   PubMed Web of Science ®Google Scholar
• Xi Q, Cheranov SY, Jaggar JH. (2005). Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2+ sparks. Circ Res 97(4):354–62.
   PubMed Web of Science ®Google Scholar
• Xin X, Yang S, Kowalski J, Gerritsen ME. (1999). Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 274(13):9116–21.
   PubMed Web of Science ®Google Scholar
• Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, Oberley LW. (2002). Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277(23):20919–26.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS. (2000). Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279(4):F671–8.
   PubMed Web of Science ®Google Scholar
• Zhou HZ, Ma X, Gray MO, Zhu BQ, Nguyen AP, Baker AJ, Simonis U, Cecchini G, Lovett DH, Karliner JS. (2007). Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem Biophys Res Commun 358(1):189–95.
   PubMed Web of Science ®Google Scholar
• Zhou J, Austin RC. (2009). Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors 35(2):120–129.
   PubMed Web of Science ®Google Scholar
• Zhou J, Moller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, Falk E. (2001). Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21(9):1470–76.
   PubMed Web of Science ®Google Scholar